Highly diastereoselective synthesis of 4-N-methylformamidino trinem (GV129606), a potent antibacterial agent

Tetrahedron

Volumn 56, Issue 31, 2000, Pages 5649-5655

  Biondi, Stefano ^a   Pecunioso, Angelo ^a   Busi, Filippo ^a   Contini, Stefania A ^a   Donati, Daniele ^a   Maffeis, Micaela ^a   Pizzi, Domenica A ^a   Rossi, Luciana ^a   Rossi, Tino ^a   Sabbatini, Fabio M ^a  

^a GSK   (Italy)

Author keywords

Diastereoselective synthesis; Gram negative bacteria; Pseudomonads; Trinems; Lactams

Indexed keywords

4 N METHYLFORMAMIDINO TRINEM; ANTIBIOTIC AGENT; GV 129606; TRINEM DERIVATIVE; UNCLASSIFIED DRUG;

CHEMICAL REACTION; CHEMICAL STRUCTURE; CONFERENCE PAPER; DRUG STRUCTURE; DRUG SYNTHESIS; PRIORITY JOURNAL; STEREOCHEMISTRY; STEREOSPECIFICITY;

EID: 0034725856     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4020(00)00414-2     Document Type: Article

References (54)

1. AA.VV. Advances in Experimental Medicine and Biology. Antimicrobial Resistance: a Crisis in Health Care; Jungkind, D. L., Mortensen, J. E., Fraimow, H. S., Calandra, G. B., Eds.; Plenum: New York, 1995; Vol. 390.
2. Mitscher L.A., Pillai S.P., Gentry E.J., Shankel D.M. Med. Res. Rev. 19:(6):1999;477-496.
3. Bush, K.; Mobashery, S. In Resolving the antibiotic paradox; Rosen, B. P., Mobashery, S., Eds.; Kluwer Academic/Plenum: New York, 1998.
4. (a) Biondi, S. Trinems: synthesis and antibacterial activity of a new generation of antibacterial β-lactams, Spec. Publ. - R. Soc. Chem., 1997; Vol. 198 (Anti-infectives), pp 86-100.
5. (b) Ghiron, C.; Rossi, T. The Chemistry of Trinems, Targets Heterocycl. Syst., 1997; Vol. 1, pp 161-186.
6. (c) Gaviraghi, G. Tribactams: a new prospect in β-lactam chemotherapy, Eur. J. Med. Chem. (Suppl. Proceedings of the 13th International Symposium on Medicinal Chemistry 1994), 1995, 467s-478s.
7. (d) Upender, V.; Kelson, A. B.; Ryan, K. J.; Webb, R. R.; Tracy, M. Synthesis and biological activity of novel trinems; Book of Abstracts; 214th ACS National Meeting, Las Vegas, NV, 7-11 September 1997; MEDI-151.
8. (a) Biondi, S.; Gaviraghi, G.; Rossi, T. Bioorg. Med. Chem. Lett. 1996, 6 (5), 525-528.
9. (b) Di Fabio, R.; Feriani, A.; Gaviraghi, G.; Rossi, T. Bioorg. Med. Chem. Lett. 1995, 5 (12), 1235-1240.
10. (c) Copar, A.; Solmajer, T. Zb. Ref. Posvetovanja Slov. Kem. Dnevi 1997, 37-42; Chem. Abstr. 130, 124904.
11. (c) Copar, A.; Solmajer, T. Zb. Ref. Posvetovanja Slov. Kem. Dnevi 1997, 37-42; Chem. Abstr. 130, 124904.
12. (d) Kawamoto, I.; Shitaji, Y.; Tracy, M.; Kelson, A. B.; Ryan, K. J.; Upender, V.; Webb, R. R. JP 11060576 A2, 1999; Chem. Abstr. 130, 252193.
13. (d) Kawamoto, I.; Shitaji, Y.; Tracy, M.; Kelson, A. B.; Ryan, K. J.; Upender, V.; Webb, R. R. JP 11060576 A2, 1999; Chem. Abstr. 130, 252193.
14. (e) Sendai, M.; Miwa, T. EP 422596 A2; Chem. Abstr. 1991, 115, 279692.
15. (e) Sendai, M.; Miwa, T. EP 422596 A2; Chem. Abstr. 1991, 115, 279692.
16. (a) Copar, A.; Solmajer, T.; Anzic. B.; Kuzman, T.; Mesar, T.; Kocjan, D. WO 9827094 A1; Chem. Abstr. 1998, 129, 95355.
17. (a) Copar, A.; Solmajer, T.; Anzic. B.; Kuzman, T.; Mesar, T.; Kocjan, D. WO 9827094 A1; Chem. Abstr. 1998, 129, 95355.
18. (a) Biondi, S.; Piga, E.; Rossi, T.; Vigelli, G. Bioorg. Med. Chem. Lett. 1997, 7 (15), 2061-2066.
19. (b) Andreotti, D.; Rossi, T.; Marchioro, C. Bioorg. Med. Chem. Lett. 1996, 6 (21), 2589-2594.
20. (c) Mori, M.; Oida, S. Jpn. Kokai Tokkyo Koho 1998, JP 10310582 A2; Chem. Abstr. 1998, 130, 52269.
21. (c) Mori, M.; Oida, S. Jpn. Kokai Tokkyo Koho 1998, JP 10310582 A2; Chem. Abstr. 1998, 130, 52269.
22. (d) Miwa, T.; Nagai, K.; Okonogi, K. Jpn. Kokai Tokkyo Koho 1994 JP 06166688 A2 Application: JP 93-21232; Chem. Abstr. 1995, 122, 9771.
23. (d) Miwa, T.; Nagai, K.; Okonogi, K. Jpn. Kokai Tokkyo Koho 1994 JP 06166688 A2 Application: JP 93-21232; Chem. Abstr. 1995, 122, 9771.
24. (a) Hanessian, S.; Griffin, A. M.; Rozema, M. J. Bioorg. Med. Chem. Lett. 1997, 7 (14), 1857-1862.
25. (b) Hanessian, S.; Rozema, M. J.; Reddy, G. B.; Braganza, J. F. Bioorg. Med. Chem. Lett. 1996, 5 (21), 2535-2540.
26. (a) Tamburini, B.; Perboni, A.; Rossi, T.; Donati, D.; Andreotti, D.; Gaviraghi, G.; Carlesso, R.; Bismara, C. Eur. Pat. Appl. EP0416953 A2, 1991; Chem. Abstr. 1992, 116, 235337t.
27. (a) Tamburini, B.; Perboni, A.; Rossi, T.; Donati, D.; Andreotti, D.; Gaviraghi, G.; Carlesso, R.; Bismara, C. Eur. Pat. Appl. EP0416953 A2, 1991; Chem. Abstr. 1992, 116, 235337t.
28. (b) Hanessian, S.; Rozema, M. J. J. Am. Chem. Soc. 1996, 118 (41), 9884-9891.
29. Perboni, A.; Rossi, T.; Gaviraghi, G.; Ursini, A.; Tarzia, G. WO 9203437, 1992; Chem. Abstr. 1992, 117, 7735m.
30. Perboni, A.; Rossi, T.; Gaviraghi, G.; Ursini, A.; Tarzia, G. WO 9203437, 1992; Chem. Abstr. 1992, 117, 7735m.
31. (a) Tamura, S.; Miyazaki, S.; Tateda, K.; Ohno, A. I. Y.; Matsumoto, T.; Furuya, N.; Yamaguchi, K. Antimicrob. Agents Chemother. 1998, 42 (7), 1858-1861.
32. (b) Ngo, J.; Castaner, J. Drugs Future 1996, 21 (12), 1238-1245.
33. (c) Di Modugno, E.; Erbetti, I.; Ferrari, L.; Galassi, G. L.; Hammond, S. M.; Xerri, L. Antimicrob. Agents Chemother. 1994, 38 (10), 2362-2368.
34. Andreotti, D.; Biondi, S.; Donati, D. Chem. Heterocycl. Compd. (NY) 1999, 34 (11), 1324-1330.
35. (b) Gehanne, S.; Piga, E.; Andreotti, D.; Biondi, S.; Pizzi, D. Bioorg. Med. Chem. Lett. 1996, 6 (22), 2791-2794.
36. (c) Tranquillini, M. E.; Araldi, G. L.; Donati, D.; Pentassuglia, G.; Pezzoli, A.; Ursini, A. Bioorg. Med. Chem. Lett. 1996, 6 (14), 1683-1688.
37. Perboni, A.; Donati, D.; Tarzia, G. Eur. Pat. Appl. EP 502468 A1, 1992; Chem. Abstr. 1993, 118, 80719.
38. Perboni, A.; Donati, D.; Tarzia, G. Eur. Pat. Appl. EP 502468 A1, 1992; Chem. Abstr. 1993, 118, 80719.
39. (3R,4R,1′R)-(+)-4-Acetoxy-3-[1′-(tert-butyldimethylsilyloxy) ethyl]azetidin-2-one 4 is commercially available from the Aldrich Chemical Company Inc., Milwaukee, WI.
40. Marchioro C., Pentassuglia G., Perboni A., Donati D. J. Chem. Soc., Perkin Trans. 1. (4):1997;463-468.
41. (a) Biondi, S.; Rossi, T.; Contini, S. A. Eur. Pat. Appl. 1994, EP 617017 A1; Chem. Abstr. 1994, 121, 280531.
42. (a) Biondi, S.; Rossi, T.; Contini, S. A. Eur. Pat. Appl. 1994, EP 617017 A1; Chem. Abstr. 1994, 121, 280531.
43. (b) Biondi, S.; Andreotti, D.; Rossi, T.; Carlesso, R.; Tarzia, G.; Perboni, A. Eur. Pat. Appl., 1992, EP 502464 A1; Chem. Abstr. 1992, 117, 251135.
44. (b) Biondi, S.; Andreotti, D.; Rossi, T.; Carlesso, R.; Tarzia, G.; Perboni, A. Eur. Pat. Appl., 1992, EP 502464 A1; Chem. Abstr. 1992, 117, 251135.
45. Rossi T., Biondi S., Contini S., Thomas R.J., Marchioro C. J. Am. Chem. Soc. 117:(37):1995;9604-9605.
46. (a) Bywood, R.; Gallagher, G.; Sharma, G. K.; Walker, D. J. Chem. Soc., Perkin Trans. 1 1975, 20, 2019-2022.
47. (b) Long, A. G.; Walker, D.; Eastlick, D. T.; Stables, H. G. Ger. Offen 1974, DE 2335083 1974; Chem. Abstr. 1974, 80, 108858.
48. (b) Long, A. G.; Walker, D.; Eastlick, D. T.; Stables, H. G. Ger. Offen 1974, DE 2335083 1974; Chem. Abstr. 1974, 80, 108858.
49. (c) Bywood, R.; Gallagher, G.; Sharma, G. K.; Walker, D. Ger. Offen. 1972, DE 2201018; Chem. Abstr. 1972, 77, 126623.
50. (c) Bywood, R.; Gallagher, G.; Sharma, G. K.; Walker, D. Ger. Offen. 1972, DE 2201018; Chem. Abstr. 1972, 77, 126623.
51. In attempts to isolate compound 17 we obtained the product in about 94%, but generally we used the crude intermediate for the cyclisation step.
52. (a) Oberholtzer, E. R. Anal. Profiles Drug Subst. 1988, 17, 73-114.
53. (b) Hazen, G. G.; Volante, R. P.; Wilson, K. E. US 4374772, 1983; Chem. Abstr. 98, 179101.
54. (b) Hazen, G. G.; Volante, R. P.; Wilson, K. E. US 4374772, 1983; Chem. Abstr. 98, 179101.